American Radium Society

ARS WELCOME

• ARS 92nd Annual Meeting: Introduction

 

PRESIDENT’S LECTURE

• President’s Lecture: Raymond Sawaya, MD; MD Anderson Cancer Center
  
  

SCIENTIFIC SESSION #1: BREAST CANCER

• Gamma Knife Perfexion at MD Anderson: Initial Experience and Illustrative Cases: Eric Chang, MD, Director CNS Stereotactic RT Program Associate Professor of Radiation Oncology.
• Gamma Knife Perfexion Introduction and Northwestern Experience: John A. Kalapurakal, MD, Professor, Radiation Oncology Director, Radiosurgery Program Northwestern University Medical School Chicago, IL.
• The FDG-PET Response of Lymph Nodes To Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer Does Not Correlate with Pathologic Response: T. Kuan Yu
• CIGARETTE SMOKING AND RISK OF CONTRALATERAL BREAST CANCER: Amar Rewari MD, MBA
• The Role of Adjuvant Therapy in Early Stage Breast Cancer Patients with a Strong Family History: Sabin B. Motwani, MD.
• Population-based Analysis of Occult Primary Breast Cancer with Axillary Nodal Metastasis: Gary V. Walker M.P.H.
• Evaluation of Adjuvant Radiation Therapy in the Management of Male Breast Cancer: A Surveillance, Epidemiology, and End Results Analysis: Usama Mahmood MD.
• Ductal Carcinoma in situ (DCIS) Treated with Wide Excision (>1cm Margins) & Accelerated Partial Breast Irradiation (APBI): Sharad Goyal.
• A prospective study evaluating tumor bed boost with intra-operative electron irradiation (IOERT) in breast conserving treatment for T1/T2 N0 breast cancer: William Wong, MD
• Phase III Study Comparing Prone Accelerated Whole Breast IMRT with a Daily vs. Weekly Tumor Bed Boost: S.C. Lymberis.

SCIENTIFIC SESSION #2: CNS Cancer/Pediatric Cancer

• A mesenchymal expression classifier predicts survival of patients with infiltrating gliomas and correlates with radiation and oncogenic gene signatures: Erik P. Sulman, MD, PH.D.
• Glioblastoma Stem Cells Mimic Molecular Subtypes of Tumors Associated with Differential Response to Radiation and Temozolomide: Howard Colman.
• Adverse Events after Gamma Knife Radiosurgery for Parafalcine Compared to Supratentorial Convexity Meningiomas: Philip Schaner Ph.D., MD
• Marginal Recurrence after Stereotactic Body Radiotherapy for Spinal Metastases Requiring Salvage Radiotherapy: Shlomo A. Koyfman, MD
• Spinal Re-irradiation Using Stereotactic Body Radiotherapy: Amit K. Garg, MD
• Infant Brain Tumors: Andrew Bishop, MS
• Is Height Impairment Present in Children with Acute Lympoblastic Leukemia after 12 to 12.6 GY Cranial Irradiation?  Arnold C. Paulino.
• An Analysis of the Safety and Efficacy of TID Hyperfractionated Total Body Irradiation as Compared to a BID Regimen in Conditioning for Bone Marrow Transplantation: Shapiro RH, Chang AL

PANEL: Technology and Outcomes

• TECHNOLOGY AND OUTCOMESROBOTIC PROSTATECTOMY: John W. Davis, MD, Assistant Professor, Urology Director, Urology Prostate Program and Ultrasound Service The University of Texas M. D. Anderson Cancer Center.
• Emerging Technology Committee (ETC) Activities and Initiatives: Jeff Michalski, MD, MBA, FACR Co-Chair, ASTRO ETC-MSC Professor and Vice-Chair Department of Radiation Oncology Mallinckrodt Institute of Radiology Washington University.
• Technology Assessment and Coverage of New Medical Technologies in Oncology: Wade M. Aubry, MD

SELF- ASSESSMENT MODULE (SAM): SMALL CELL LUNG CANCER - Kenneth E. Rosenzweig, MD; Memorial Sloan Kettering Cancer Center


KEYNOTE LECTURE: MDACC-RTOG Alliance in Customizing Head & Neck Cancer Therapy - K. Kian Ang, MD, PhD; MD Anderson Cancer Center

SCIENTIFIC SESSION #3: HEAD AND NECK CANCER

• A Predictive Model of Human Papilloma Virus (HPV) Positivity in Head and Neck Cancer Patients: Alan T. Monroe, MD
• Post-Radiation Threshold Tumor Volume Predicts Outcome in Head-and-Neck Cancer James D. Murphy, MD
• CT-Based Tumor-Volume Could Be the Best Prognosticator for Local Control and Organ Preservation of Larynx Cancer Patients After Definitive Conformal Accelerated Radiation Therapy: Krzysztof Skladowski, MD, PhD
• Enhanced Radiation-Induced DNA Damage and Cell Death With the Use of an Orally Bioavailable PARP1 Inhibitor Olaparib (AZD2281) in BRCA1/BRCA2 Wild-Type Head and Neck Squamous Cell Carcinoma Cell Lines: David Raben, MD
• Treatment of Carcinomas of the Nasal Vestibule With Interstitial Irradiation: Jack Phan, MD, PhD
• Stereotactic Radiotherapy in Stage I Non Small Cell Lung Cancer: Ben J. Slotman, MD, PhD
• Predictors of Chest Wall Toxicity Following Stereotactic Body Radiotherapy for Early Stage Non-Small Cell Lung Cancer: Robert Mutter - TRAVEL GRANT WINNER
• Clinical Outcomes of Patients With Malignant Lung Lesions Treated With Stereotactic Body Radiation Therapy: Hua Ren, MD, PhD
• A Polymorphism in the Promoter of the TGF-Beta Gene is Associated With Radiation Sensitivity Using an Objective Radiologic Endpoint: Chris R. Kelsey, MD
  
  

SCIENTIFIC SESSION #4: LUNG/THORACIC CANCER

• The Benefit of Consolidative Radiation Therapy in Patients With Diffuse Large B-Cell Lymphoma Treated With RCHOP Chemotherapy: Jack Phan, MD, PhD - TRAVEL GRANT WINNER
• A Novel Method for Transcutaneous Gene Therapy Silences Smad3: Gene Expression Profiles of Radiation Fibrosis Investigated: Judy W. Lee, MD
• Dose-Dependent Radioprotection by Antagonists of Growth Hormone Releasing Hormone Given Before Whole Body Radiation is Dependent on Organ-Specific Upregulation of Target Genes: May Abdel-Wahab, MD
• Somatostatin Receptor Subtype 2-Targeted Copper Radiopharmaceuticals for Cancer Imaging and Therapy: Albert J. Chang, MD, PhD - TRAVEL GRANT WINNER
• Comparison of Gross Tumor Volumes as Measured by Micro FDG-PET/CT to Pathologic Tumor Volumes in a Mouse Model: Jennifer Hoefert, BA
• Morbid Obesity and Heterotopic Ossification Waleed: F. Mourad, MD, MSc - TRAVEL GRANT WINNER
• Male Cancer Survivor Use of Internet-Based Survivorship Care Plans: Christine Hill-Kayser, MD

PANEL: SARCOMA

• The Epidermal Growth Factor Receptor and Lung Cancer: Jeffrey A. Bogart, MD SUNY Upstate Medical Center
• Co-Targeting IGF-1R with EGFR in Combination with Radiation: K. Kian Ang, MD, PhD MD Anderson Cancer Center
• Targeted Therapy: At what point is the Gun too expensive: Andre A. Konski, MD, MBA, MA Wayne State School of Medicine
• Biomarkers for Lung Cancer Therapy: Anne S. Tsao, MD MD Anderson Cancer Center

 

JANEWAY LECTURE: Melanoma as an Example of Evidence-Based Medicine

Charles M. Balch, MD, Johns Hopkins Medical Institute

SCIENTIFIC SESSION #5: CNS/ PEDS/LYMPHOMA/SARCOMA

• Mediator of DNA Damage Checkpoint Protein 1 (MDC1) Expression as a Prognostic Marker for Nodal Recurrence in Early-Stage Breast Cancer Patients Treated With Breast-Conserving Surgery and Radiation Therapy: Akshar N. Patel, BS
• MammoSite Brachytherapy Versus Whole Breast Irradiation:
  Analysis of Patient Outcomes Stratified by the ASTRO Consensus Statement Groups for Accelerated Partial Breast Irradiation: A. Jason Zauls, MD
• Down-Regulation of MicroRNA 106b Is Involved in p21-Mediated Cell Cycle Arrest in Response to Radiation in Prostate Cancer Cells: Baoqing Li, MD, PhD
• What is the Role of Radiation Therapy in Stage I and II Hodgkin’s Disease?
  Matthew Koshy, MD
• Postoperative Radiotherapy Use and Patterns of Care Analysis for Node Positive or Parametria Positive Cervical Cancer: Amol J. Ghia, MD
• Prognostic Utility of Squamous Cell Carcinoma Antigen in Carcinoma of the Cervix: Correlation with Pre- and Post-Treatment FDG-PET: Jeffrey R. Olsen, MD

Proton Therapy for Lung/Prostate:

• Should Randomized Studies be Required for Adopting New Technologies? James D. Cox, MD, Anderson Cancer Center
• Randomized Trials of ProtonTherapy are needed in Lung and Prostate Cancer:
  Joel E. Tepper, MD; University of North Carolina School of Medicine
• Economic Considerations for Proton Therapy: James D. Cox, MD, Anderson Cancer Center

SCIENTIFIC SESSION #6: BREAST CANCER

• Biomarker Expression Can Identify Biologically Distinct Categories of Invasive Breast Cancer:
  J.Y. Shim, MD - TRAVEL GRANT WINNER
• Association Between Locoregional Outcomes and Biologic Subtype in Locally Advanced Breast Cancer (LABC): Cristiane Takita, MD
• COX-2 Correlates With Risk of Ipsilateral Breast Tumor Recurrence Early-Stage Breast Cancer Patients Treated With Breast-Conserving Surgery and Radiation Therapy:
  Atif J. Khan, MD, MS
• Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Negative or ER-PR+ Breast Cancer Predicts Locoregional Recurrence But Not Distant Metastases Compared to ER+PR+ Disease in Patients With Node-Negative Disease and Tumors One Centimeter or Less:
  Jeffrey M. Albert, MD
• Local-Regional Outcomes in Triple-Negative Breast Cancer Patients Who Receive Breast Conservation Therapy: Stephen H. Settle, MD, PhD
• GM-CSF and IFN-Gamma Up-Regulation With Stereotactic Body Radiation Therapy for Oligometastatic Breast Cancer Correlates With Improved Overall Survival:
  Su K. Metcalfe, MD, MPH

PANEL: CNS/SRS

• Impact of ioMRI on Extent of Resection in Surgery for Brain Tumors: Jeffrey Weinberg, MD MD Anderson Cancer Center
• Update on current trends in the management of spinal tumors: Eric Chang, MD MD Anderson Cancer Center
• Radiosurgery for Benign Spinal Tumors and Functional Applications: Iris C. Gibbs, MD Stanford School of Medicine

SELF-ASSESSMENT MODULE (SAM): PEDIATRIC CANCER

• LONG-TERM TOXICITY OF RADIOTHERAPY IN CHILDREN:
  Arnold C. Paulino, MD, The Methodist Hospital

KEYNOTE SPEAKER

• Molecular Imaging Guided Radiation Oncology:
  Richard Wahl, MD, Johns Hopkins University School of Medicine

SCIENTIFIC SESSION #7: GENITO-URINARY CANCER

• Different Planning Software Could Lead to Different Dosimetric Results: Matched-Pair Analysis of Two Types of Software for Interstitial Permanent Brachytherapy for Prostate Cancer
  Hiromichi Ishiyama, MD
• Single Institution Experience with Cesium-131 Brachytherapy for Prostate Cancer Patients
  Aaron W. Pederson, MD
• Shorter Treatment Time Reduces Intrafraction Prostate Motion: Jay Shelton, MD
• Pelvic Nodal Dose Escalation With Simultaneous Integrated Hypofractionated Prostate IMRT for High Risk Prostate Cancer: Jarrod B. Adkison, MD
• Analysis of Pathologic Extent of Disease for Clinically Localized Prostate Cancer After Radical Prostatectomy and Subsequent Use of Adjuvant Radiation in a National Cohort
  David Schreiber, MD - TRAVEL GRANT WINNER
• Dynamic Contrast Enhanced (DCE) MRI Post-Prostatectomy for a Rising PSA: Implications for Radiotherapy: Raj S. Rajpara, BS
• Multi-Modal Real-Time Three-Dimensional Ultrasound-Based Imaging for Detection of Prostate Cancer in Men: Hans T. Chung, MD, FRCPC

SCIENTIFIC SESSION #8: GASTRO-INTESTINAL CANCER/GYNECOLOGIC CANCER

• Factors Influencing Survival in Patients Undergoing a Palliative Bypass Procedure for Pancreatic Adenocarcinoma: Phillip J. Gray, MD, The Johns Hopkins Experience
• Multiinstitutional Phase II Trial of Induction Cetuximab Gemcitabine and Oxaliplatin, Followed By Radiotherapy With Concurrent Capecitabine, and Cetuximab, for Locally Advanced Pancreatic Adenocarcinoma (LAPC): Christopher H. Crane, MD
• Outcome Analysis of Intensity Modulated Radiation Therapy and Concurrent Chemoradiation Therapy for Anal Carcinoma in NCI-Designated Integrated Cancer Center Network
  Sarahgene G. DeFoe, MD
• Prospective Trial of Stereotactic Body Radiation Therapy for Colorectal Oligometastases
  Su K. Metcalfe, MD, MPH
• FDG-PET-Based Prognostic Nomogram for Locally Advanced Cervical Cancer
  Elizabeth A. Kidd, MD - TRAVEL GRANT WINNER
• Chemoradiation Response-Suppressing Potential of Ribonucleotide Reductase p53R2 in Cervical Cancers: Charles Kunos, MD, PhD
• Contemporary Analysis of Pelvic and Para-Aortic Metastasis in Endometrial Cancer Using the SEER Database: Evangelia Katsoulakis, MD

PANEL: LIVER TUMORS

• Management of Colorectal Hepatic Metastases: Elin R. Sigurdson, MD, PhD, Fox Chase Cancer Center
• Economic impact of treatment metastatic colorectal cancer: Yu-Ning Wong, MD, MSCE, Fox Chase Cancer Center
• Laparoscopic Liver Surgery: Andrew A. Gumbs, MD, Fox Chase Cancer Center
• Stereotactic Body Radiotherapy for Liver Metastasis: Higinia R. Cardenes, MD, PhD, Indiana University